Dorsey Wright & Associates Pds Biotechnology Corp Transaction History

Dorsey Wright & Associates

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 27, 2022	SELL	$7.76 - $14.35 $34,338 - $63,498	-4,425 Closed	0 $0
Q3 2021 Oct 26, 2021	BUY	$9.33 - $17.08 $3,246 - $5,943	348 Added 8.54%	4,425 $66,000
Q2 2021 Jul 23, 2021	BUY	$4.35 - $12.86 $17,734 - $52,430	4,077 New	4,077 $51,000

7.53M

140K

318K

Ticker PDSB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,458,700
Market Cap $88.8M
Description
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

Stay updated on Dorsey Wright & Associates with notifications on news.